SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004378
Filing Date
2021-11-12
Accepted
2021-11-12 16:08:00
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alna-20210930.htm   iXBRL 10-Q 2805399
2 EX-31.1 alna-ex31_1.htm EX-31.1 17923
3 EX-31.2 alna-ex31_2.htm EX-31.2 17905
4 EX-32.1 alna-ex32_1.htm EX-32.1 14238
  Complete submission text file 0000950170-21-004378.txt   7713369

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alna-20210930_cal.xml EX-101.CAL 37410
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alna-20210930_def.xml EX-101.DEF 182927
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alna-20210930.xsd EX-101.SCH 41783
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alna-20210930_lab.xml EX-101.LAB 372081
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alna-20210930_pre.xml EX-101.PRE 293616
10 EXTRACTED XBRL INSTANCE DOCUMENT alna-20210930_htm.xml XML 1086369
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 211403476
SIC: 2836 Biological Products, (No Diagnostic Substances)